Biochemical and Pharmacologic Heterogeneity in Low Molecular Weight Heparins. Impact on the Therapeutic Profile

By  

Current Pharmaceutical Design, Vol. 10, Iss. 9, 2004-04 ,pp. : 983-999

Bentham Science Publishers

Access to resources Recommend Favorite

Low molecular weight heparins

By Aguilar O.M.   Kleiman N.S.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1091-1103

Informa Healthcare

Access to resources Recommend Favorite

Safety of low molecular weight heparins in the treatment of venous thromboembolism

By Bernardi Enrico   Prandoni Paolo  

Expert Opinion on Drug Safety, Vol. 2, Iss. 1, 2003-01 ,pp. : 87-94

Informa Healthcare

Access to resources Recommend Favorite

The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke

By Kiphuth Ines C   Köhrmann Martin   Huttner Hagen B   Schellinger Peter D  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 585-597

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular Weight Heparins in Percutaneous Coronary Interventions: Current Concepts, Problems, and Perspectives

By  

Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. : 375-386

Bentham Science Publishers

Access to resources Recommend Favorite